Founded in 2025 in south Florida, MOLTHERA is an early PoC-preclinical stage combination biologic/device company developing next generation cancer treatments.

We are developing the ImmunoRod^TM, a first-in-class, local immuno-stromal therapy platform for treatment of solid tumors.

Follow us on X as we work to build innovative best-in-class cancer treatments for hard-to-treat tumors.